Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D03DMA
|
||||
Former ID |
DNC007686
|
||||
Drug Name |
Geranylcoumarin
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528768] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H22O3
|
||||
Canonical SMILES |
CC(C)C=CCC(=CCOC1=CC2=C(C=C1)C=CC(=O)O2)C
|
||||
InChI |
1S/C19H22O3/c1-14(2)5-4-6-15(3)11-12-21-17-9-7-16-8-10-19(20)22-18(16)13-17/h4-5,7-11,13-14H,6,12H2,1-3H3/b5-4+,15-11+
|
||||
InChIKey |
KAYCKFWCZGZEHA-WEPZFIBGSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cytochrome P450 3A4 | Target Info | Inhibitor | [528768] | |
PathWhiz Pathway | Caffeine Metabolism | ||||
Retinol Metabolism | |||||
WikiPathways | Metapathway biotransformation | ||||
Aflatoxin B1 metabolism | |||||
Estrogen metabolism | |||||
Benzo(a)pyrene metabolism | |||||
Tamoxifen metabolism | |||||
Tryptophan metabolism | |||||
Oxidation by Cytochrome P450 | |||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Nuclear Receptors Meta-Pathway | |||||
Farnesoid X Receptor Pathway | |||||
Vitamin D Receptor Pathway | |||||
Felbamate Metabolism | |||||
Lidocaine metabolism | |||||
Nifedipine Activity | |||||
Colchicine Metabolic Pathway | |||||
Irinotecan Pathway | |||||
Drug Induction of Bile Acid Pathway | |||||
Fatty Acid Omega Oxidation | |||||
Codeine and Morphine Metabolism | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.